(3β,5β,6β)-(25,26,26,26,27,27,27-2H7)-5,6-Epoxycholestan-3-ol

Modify Date: 2024-05-01 20:14:09

(3β,5β,6β)-(25,26,26,26,27,27,27-2H7)-5,6-Epoxycholestan-3-ol structure	Common Name	(3β,5β,6β)-(25,26,26,26,27,27,27-2H7)-5,6-Epoxycholestan-3-ol
	CAS Number	127684-06-4	Molecular Weight	409.696
	Density	1.0±0.1 g/cm3	Boiling Point	497.7±18.0 °C at 760 mmHg
	Molecular Formula	C₂₇H₃₉D₇O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	200.9±15.5 °C

Use of (3β,5β,6β)-(25,26,26,26,27,27,27-2H7)-5,6-Epoxycholestan-3-ol

5β,6β-Epoxycholestanol-d7 is deuterium labeled 5β,6β-Epoxycholestanol.

Name	(3β,5β,6β)-(25,26,26,26,27,27,27-2H7)-5,6-Epoxycholestan-3-ol
Synonym	More Synonyms

Description	5β,6β-Epoxycholestanol-d7 is deuterium labeled 5β,6β-Epoxycholestanol.
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[2].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.

Density	1.0±0.1 g/cm3
Boiling Point	497.7±18.0 °C at 760 mmHg
Molecular Formula	C₂₇H₃₉D₇O₂
Molecular Weight	409.696
Flash Point	200.9±15.5 °C
Exact Mass	409.393707
LogP	8.07
Vapour Pressure	0.0±2.9 mmHg at 25°C
Index of Refraction	1.533

Cholestan-25,26,26,26,27,27,27-d-3-ol, 5,6-epoxy-, (3β,5β,6β)-

(3β,5β,6β)-(25,26,26,26,27,27,27-H)-5,6-Epoxycholestan-3-ol